58:32
Bruce Willis has Frontotemporal Dementia: What are the symptoms of FTD
57:27
The New Alzheimer’s Drug: What is Leqembi?
01:07
Is Inflammation the Answer? A Potential Future Treatment for Age-Related Macular Degeneration
00:52
Researchers Study Brain Benefits of Exercise in Older African Americans (30 sec)
02:25
Researchers Study Brain Benefits of Exercise in Older African Americans
04:05
Entendiendo el glaucoma: respuesta a sus principales preguntas
00:43
Understanding Glaucoma: Your Top Questions Answered
04:02
Understanding Glaucoma: Your Top Questions Answered
00:16
Buscando respuestas en la lucha contra el Alzheimer - Historia de Phil (15 segundos)
00:16
Finding Answers in the Fight Against Alzheimer's - Phil's Story (15 sec)
00:31
Buscando respuestas en la lucha contra el Alzheimer - Historia de Phil (30 segundos) B
00:31
Finding Answers in the Fight Against Alzheimer's - Phil's Story (30 sec) B
00:31
Buscando respuestas en la lucha contra el Alzheimer - Historia de Phil (30 segundos)
00:31
Finding Answers in the Fight Against Alzheimer's - Phil's Story (30 sec)
01:01
Buscando respuestas en la lucha contra el Alzheimer - Historia de Phil
01:01
Finding Answers in the Fight Against Alzheimer's - Phil's Story (60 sec)
00:31
BrightFocus Phil s Story 30secB HD
00:31
BrightFocus Phil s Story 30secA HD
00:16
Finding Answers in the Fight Against Alzheimer's - Phil's Story
02:52
BrightFocus Foundation 2022 Bench to Bedside Award Winner Ilyas Washington, PhD
01:48
Researcher Q&A: Growing Cells for Glaucoma
01:15
Why Does Alzheimer’s Disease Affect More Women Than Men?
03:03
Researcher Spotlight: BrightFocus Foundation 2022 Scientific Impact Award Winner David Holtzman, MD
02:56
Glaucoma - Advancements in Research
02:34
Diagnosing Glaucoma
02:54
Treatments for Age-Related Macular Degeneration
04:54
Alzheimer's Day of Hope
15:27
John Lewis Video + Fitness Tips for Everyone
10:31
Grant Writing Tips
06:29
John Lewis Exercise Video for Brain Info Live
X
About
BrightFocus Foundation is a nonprofit organization supporting research and providing public education to help eradicate Alzheimer's disease, macular degeneration, and glaucoma. Through our flagship programs — Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research — we have invested nearly $300 million in research grants, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools.
To learn more, visit brightfocus.org.
Tags